{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:56:17Z","timestamp":1775210177758,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10096-015-2344-7","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T03:08:08Z","timestamp":1425870488000},"page":"1255-1262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Potential chitosan-coated alginate nanoparticles for ocular delivery of daptomycin"],"prefix":"10.1007","volume":"34","author":[{"given":"J. R.","family":"Costa","sequence":"first","affiliation":[]},{"given":"N. C.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"B.","family":"Sarmento","sequence":"additional","affiliation":[]},{"given":"M.","family":"Pintado","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.15.1.111-124.2002","volume":"15","author":"MC Callegan","year":"2002","unstructured":"Callegan MC, Engelbert M, Parke DW 2nd, Jett BD, Gilmore MS (2002) Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium\u2013host interactions. Clin Microbiol Rev 15:111\u2013124","journal-title":"Clin Microbiol Rev"},{"key":"2344_CR2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9394(99)00112-9","volume":"128","author":"DY Kunimoto","year":"1999","unstructured":"Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, Athmanathan S, Rao TN (1999) Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 128:240\u2013242","journal-title":"Am J Ophthalmol"},{"key":"2344_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.preteyeres.2006.12.001","volume":"26","author":"MC Callegan","year":"2007","unstructured":"Callegan MC, Gilmore MS, Gregory M, Ramadan RT, Wiskur BJ, Moyer AL, Hunt JJ, Novosad BD (2007) Bacterial endophthalmitis: therapeutic challenges and host\u2013pathogen interactions. Prog Retin Eye Res 26:189\u2013203","journal-title":"Prog Retin Eye Res"},{"key":"2344_CR4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.clinthera.2004.11.014","volume":"26","author":"L Jeu","year":"2004","unstructured":"Jeu L, Fung HB (2004) Daptomycin: a cyclic lipopeptide antimicrobial agent. Clin Ther 26:1728\u20131757","journal-title":"Clin Ther"},{"key":"2344_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2007.05.180","volume":"55","author":"DA Enoch","year":"2007","unstructured":"Enoch DA, Bygott JM, Daly ML, Karas JA (2007) Daptomycin. J Infect 55:205\u2013213","journal-title":"J Infect"},{"key":"2344_CR6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131\u20131135","journal-title":"Adv Drug Deliv Rev"},{"key":"2344_CR7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","volume":"62","author":"M Fuente de la","year":"2010","unstructured":"de la Fuente M, Ravi\u00f1a M, Paolicelli P, Sanchez A, Seijo B, Alonso MJ (2010) Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 62:100\u2013117","journal-title":"Adv Drug Deliv Rev"},{"key":"2344_CR8","doi-asserted-by":"crossref","unstructured":"Silva NC, Silva S, Sarmento B, Pintado M (2013) Chitosan nanoparticles for daptomycin delivery in ocular treatment of bacterial endophthalmitis. Drug Deliv ID:858195. doi: 10.3109\/10717544.2013.858195","DOI":"10.3109\/10717544.2013.858195"},{"key":"2344_CR9","first-page":"513","volume":"68","author":"SK Motwani","year":"2008","unstructured":"Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK (2008) Chitosan\u2013sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 68:513\u2013525","journal-title":"Eur J Pharm Biopharm"},{"key":"2344_CR10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejps.2012.08.008","volume":"47","author":"RC Nagarwal","year":"2012","unstructured":"Nagarwal RC, Kumar R, Pandit JK (2012) Chitosan coated sodium alginate\u2013chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Eur J Pharm Sci 47:678\u2013685","journal-title":"Eur J Pharm Sci"},{"key":"2344_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jbm.1029","volume":"58","author":"XL Yan","year":"2001","unstructured":"Yan XL, Khor E, Lim LY (2001) Chitosan\u2013alginate films prepared with chitosans of different molecular weights. J Biomed Mater Res 58:358\u2013365","journal-title":"J Biomed Mater Res"},{"key":"2344_CR12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:PHAM.0000026432.75781.cb","volume":"21","author":"AM Campos de","year":"2004","unstructured":"de Campos AM, Diebold Y, Carvalho ELS, S\u00e1nchez A, Alonso MJ (2004) Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 21:803\u2013810","journal-title":"Pharm Res"},{"key":"2344_CR13","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s10856-008-3486-2","volume":"19","author":"W Liu","year":"2008","unstructured":"Liu W, Griffith M, Li F (2008) Alginate microsphere\u2013collagen composite hydrogel for ocular drug delivery and implantation. J Mater Sci Mater Med 19:3365\u20133371","journal-title":"J Mater Sci Mater Med"},{"key":"2344_CR14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mabi.201100419","volume":"12","author":"S Liu","year":"2012","unstructured":"Liu S, Jones L, Gu FX (2012) Nanomaterials for ocular drug delivery. Macromol Biosci 12:608\u2013620","journal-title":"Macromol Biosci"},{"key":"2344_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4314\/tjpr.v6i1.14643","volume":"6","author":"S Sangeetha","year":"2007","unstructured":"Sangeetha S, Venkatesh DN, Adhiyaman R, Santhi K, Suresh B (2007) Formulation of sodium alginate nanospheres containing amphotericin B for the treatment of systemic candidiasis. Trop J Pharm Res 6:653\u2013659","journal-title":"Trop J Pharm Res"},{"key":"2344_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1461-5347(98)00087-X","volume":"1","author":"S Ding","year":"1998","unstructured":"Ding S (1998) Recent developments in ophthalmic drug delivery. Pharm Sci Technol Today 1:328\u2013335","journal-title":"Pharm Sci Technol Today"},{"key":"2344_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.12.018","volume":"136","author":"RC Nagarwal","year":"2009","unstructured":"Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK (2009) Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 136:2\u201313","journal-title":"J Control Release"},{"key":"2344_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0142-9612(01)00094-1","volume":"23","author":"FL Mi","year":"2002","unstructured":"Mi FL, Tan YC, Liang HF, Sung HW (2002) In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 23:181\u2013191","journal-title":"Biomaterials"},{"key":"2344_CR19","first-page":"65","volume":"2012","author":"V Tamboli","year":"2012","unstructured":"Tamboli V, Mishra GP, Mitra AK (2012) Biodegradable polymers for ocular drug delivery. Adv Ocul Drug Deliv 2012:65\u201386","journal-title":"Adv Ocul Drug Deliv"},{"key":"2344_CR20","first-page":"155","volume":"88","author":"P Severino","year":"2007","unstructured":"Severino P, Vasconcellos FC, Figueiredo ES (2007) Uso t\u00f3pico de quitosana em oftalmologia. Rev Bras Farm 88:155\u2013158","journal-title":"Rev Bras Farm"},{"key":"2344_CR21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.reactfunctpolym.2008.03.002","volume":"68","author":"VK Mourya","year":"2008","unstructured":"Mourya VK, Inamdar NN (2008) Chitosan-modifications and applications: opportunities galore. React Funct Polym 68:1013\u20131051","journal-title":"React Funct Polym"},{"key":"2344_CR22","first-page":"113","volume-title":"Biodegradable polymers in clinical use and clinical development","author":"A Subramanian","year":"2011","unstructured":"Subramanian A, Vasanthan KS, Krishnan UM, Sethuraman S (2011) Chitosan and its derivatives in clinical use and applications. In: Domb AJ, Kumar N, Ezra A (eds) Biodegradable polymers in clinical use and clinical development. Wiley, New Jersey, pp 113\u2013135"},{"key":"2344_CR23","doi-asserted-by":"crossref","unstructured":"Zahoor A, Sharma S, Khuller GK (2005) Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 26:298\u2013303","DOI":"10.1016\/j.ijantimicag.2005.07.012"},{"key":"2344_CR24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/bmc.616","volume":"20","author":"B Sarmento","year":"2006","unstructured":"Sarmento B, Ribeiro A, Veiga F, Ferreira D (2006) Development and validation of a rapid reversed-phase HPLC method for the determination of insulin from nanoparticulate systems. Biomed Chromatogr 20:898\u2013903","journal-title":"Biomed Chromatogr"},{"key":"2344_CR25","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","volume":"24","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D (2007) Alginate\/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24:2198\u20132206","journal-title":"Pharm Res"},{"key":"2344_CR26","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2003) Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, NCCLS document M7-A6, 6th edition. Villanova, Pennsylvania, USA"},{"key":"2344_CR27","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing, 15th informational supplement, NCCLS document M100-S15. Villanova, Pennsylvania, USA"},{"key":"2344_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/exer.1996.0020","volume":"62","author":"KC Dunn","year":"1996","unstructured":"Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155\u2013169","journal-title":"Exp Eye Res"},{"key":"2344_CR29","first-page":"238","volume":"4","author":"J Barar","year":"2009","unstructured":"Barar J, Asadi M, Mortazavi-Tabatabaei SA, Omidi Y (2009) Ocular drug delivery impact of in vitro cell culture models. J Ophthalmic Vis Res 4:238\u2013252","journal-title":"J Ophthalmic Vis Res"},{"key":"2344_CR30","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1167\/iovs.04-1487","volume":"46","author":"RC Geiger","year":"2005","unstructured":"Geiger RC, Waters CM, Kamp DW, Glucksberg MR (2005) KGF prevents oxygen-mediated damage in ARPE-19 cells. Invest Ophthalmol Vis Sci 46:3435\u20133442","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2344_CR31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","volume":"16","author":"A Zimmer","year":"1995","unstructured":"Zimmer A, Kreuter J (1995) Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 16:61\u201373","journal-title":"Adv Drug Deliv Rev"},{"key":"2344_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"ML Hans","year":"2002","unstructured":"Hans ML, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6:319\u2013327","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"2344_CR33","unstructured":"Chen A, Haddad D, Wang R (2009) Analysis of chitosan-alginate bone scaffolds. Rutgers University, New Jersey Governor\u2019s School of Engineering & Technology"},{"key":"2344_CR34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.foodhyd.2005.05.005","volume":"20","author":"T Harnsilawat","year":"2006","unstructured":"Harnsilawat T, Pongsawatmanit R, McClements DJ (2006) Characterization of \u03b2-lactoglobulin\u2013sodium alginate interactions in aqueous solutions: a calorimetry, light scattering, electrophoretic mobility and solubility study. Food Hydrocoll 20:577\u2013585","journal-title":"Food Hydrocoll"},{"key":"2344_CR35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1248\/cpb.58.1423","volume":"58","author":"K Nagpal","year":"2010","unstructured":"Nagpal K, Singh SK, Mishra DN (2010) Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 58:1423\u20131430","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2344_CR36","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1128\/AAC.45.6.1919-1922.2001","volume":"45","author":"AL Barry","year":"2001","unstructured":"Barry AL, Fuchs PC, Brown SD (2001) In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother 45:1919\u20131922","journal-title":"Antimicrob Agents Chemother"},{"key":"2344_CR37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/jac\/49.3.467","volume":"49","author":"PC Fuchs","year":"2002","unstructured":"Fuchs PC, Barry AL, Brown SD (2002) In vitro bactericidal activity of daptomycin against staphylococci. J Antimicrob Chemother 49:467\u2013470","journal-title":"J Antimicrob Chemother"},{"key":"2344_CR38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/AAC.48.3.1007-1011.2004","volume":"48","author":"AC Fluit","year":"2004","unstructured":"Fluit AC, Schmitz FJ, Verhoef J, Milatovic D (2004) In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants. Antimicrob Agents Chemother 48:1007\u20131011","journal-title":"Antimicrob Agents Chemother"},{"key":"2344_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2005.01.009","volume":"60","author":"M Hornof","year":"2005","unstructured":"Hornof M, Toropainen E, Urtti A (2005) Cell culture models of the ocular barriers. Eur J Pharm Biopharm 60:207\u2013225","journal-title":"Eur J Pharm Biopharm"},{"key":"2344_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejps.2010.04.001","volume":"40","author":"E Mannermaa","year":"2010","unstructured":"Mannermaa E, Reinisalo M, Ranta V-P, Vellonen K-S, Kokki H, Saarikko A, Kaarniranta K, Urtti A (2010) Filter-cultured ARPE-19 cells as outer blood\u2013retinal barrier model. Eur J Pharm Sci 40:289\u2013296","journal-title":"Eur J Pharm Sci"},{"key":"2344_CR41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tox.2014.02.012","volume":"319","author":"N Nagai","year":"2014","unstructured":"Nagai N, Ito Y, Okamoto N, Shimomura Y (2014) A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology 319:53\u201362","journal-title":"Toxicology"},{"key":"2344_CR42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","volume":"83","author":"F Antunes","year":"2013","unstructured":"Antunes F, Andrade F, Ara\u00fajo F, Ferreira D, Sarmento B (2013) Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 83:427\u2013435","journal-title":"Eur J Pharm Biopharm"},{"key":"2344_CR43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2010.08.002","volume":"29","author":"Y Diebold","year":"2010","unstructured":"Diebold Y, Calonge M (2010) Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 29:596\u2013609","journal-title":"Prog Retin Eye Res"},{"key":"2344_CR44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","volume":"224","author":"AM Campos De","year":"2001","unstructured":"De Campos AM, S\u00e1nchez A, Alonso MJ (2001) Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 224:159\u2013168","journal-title":"Int J Pharm"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2344-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2344-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2344-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:35:15Z","timestamp":1559108115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2344-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2344-7","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}